Autopsy report · NCT05491902
Pilot PET Study of Regional Cerebral Protein Synthesis in Alzheimer's
Cause of deathStaffing, sites or logistics, also drug or device supply
“11C-leucine no longer available at Wolfson Molecular Imaging Centre (after suspension of recruitment due to COVID pandemic)”
Life of this trial
- Registered 4 years after it had already started.
- Ran for about 3 years before it stopped.
- 10 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- University of Manchester
- Sponsor type
- University, hospital or other
- Conditions
- Alzheimer Disease
- Interventions
- [C11] Leucine PET scan; [18F] Flutemetamol PET scan; MRI scan
- Participants
- 10
- Sites
- 2
- Countries
- United Kingdom
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.